Werfen Executive and Leadership Team

Antonio Rigual, the Chief Executive Officer at Werfen, directs the company's overarching strategy and global operations. Rigual guides the organization's expansion in the in-vitro diagnostic equipment and supplies sector, ensuring alignment with market demands and technological advancements. Overseeing all executive functions, Antonio Rigual drives the company's mission to improve patient outcomes through innovative diagnostic solutions. This leadership role involves fostering a culture of continuous improvement and strategic growth across all business units. Rigual's focus remains on strengthening Werfen's position as a leader in the healthcare diagnostics industry, ensuring sustainable development and operational excellence throughout the organization.

Dominique Petitgenet, the Executive Vice President & Chief Financial Officer at Werfen, directs all financial planning, management, and reporting for the organization. Petitgenet oversees capital allocation, investment strategies, and financial risk management to ensure the company's fiscal health and growth. Managing global financial operations, Dominique Petitgenet provides critical insights to support strategic decision-making and maintain investor confidence. This role is integral to Werfen's expansion efforts, ensuring robust financial structures are in place to support the development and distribution of in-vitro diagnostic equipment and supplies. Petitgenet's expertise safeguards the company's financial stability and drives shareholder value.

Giovanni Russi, the Chief Operating Officer at Werfen, manages the day-to-day operational execution and efficiency across the company's manufacturing and supply chain. Russi ensures that the production of in-vitro diagnostic equipment and supplies meets rigorous quality standards and demand. Overseeing global operational frameworks, Giovanni Russi optimizes processes to enhance productivity and reduce costs. This critical role involves coordinating cross-functional teams to achieve strategic objectives and maintain seamless business continuity. Russi's leadership ensures that Werfen's operational capabilities consistently support its market expansion and commitment to delivering advanced diagnostic tools to healthcare providers worldwide.

William Cork, the Chief Technology Officer at Werfen, spearheads technological innovation and development for the company's in-vitro diagnostic equipment and supplies. Cork directs research and development initiatives, focusing on creating next-generation diagnostic solutions that enhance accuracy and efficiency. Overseeing the technology roadmap, William Cork ensures Werfen remains at the forefront of diagnostic innovation. This position involves managing intellectual property, driving digital transformation, and integrating advanced technologies into product lines. Cork's strategic vision guides the technological evolution of Werfen, solidifying its competitive edge in the global healthcare market.

Annie Winkler, the Chief Medical Officer at Werfen, provides critical medical and scientific expertise to guide the development and application of the company's in-vitro diagnostic equipment and supplies. Winkler ensures that all products align with clinical needs and regulatory standards, enhancing their value to healthcare professionals. Overseeing clinical strategy and medical affairs, Annie Winkler bridges the gap between scientific innovation and patient care. This role involves collaborating with research teams, advising on clinical trials, and ensuring the efficacy and safety of diagnostic solutions. Winkler's medical leadership reinforces Werfen's commitment to advancing healthcare through accurate and reliable diagnostic tools.